b-19 czv
cz veterinaria, s.a. - brucella abortus, viva atenuada (fase lisa), cepa b-19 - liofilizado y disolvente para suspensiÓn inyectable - excipientes: ascorbico acido (e 300), glicina, lactosa, tiourea, triptona, agua para preparaciones inyectables, cloruro de sodio, agua para preparaciones inyectables - vacunas bacterianas vivas - bovino
covid-19 vaccine (inactivated, adjuvanted) valneva
valneva austria gmbh - covid-19 vaccine (inactivated, adjuvanted, adsorbed) - covid-19 virus infection - vacunas - covid-19 vaccine (inactivated, adjuvanted) valneva is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 18 to 50 years of age. the use of this vaccine should be in accordance with official recommendations.
b-19 czv subcutanea # b-19 czv liofilizado y disolvente para suspensión inyectable
cz vaccines s.a.u. - brucella abortus, viva atenuada (fase lisa), cepa b-19 - liofilizado y disolvente para suspensiÓn inyectable - brucella abortus, viva atenuada (fase lisa), cepa b-19 6-12x10^10 - vacunas bacterianas vivas - bovino
b-19 czv oftalmica polvo y disolvente para colirio en suspensión
cz vaccines s.a.u. - brucella abortus, viva atenuada (fase lisa), cepa b-19 - polvo y disolvente para colirio en suspensiÓn - brucella abortus, viva atenuada (fase lisa), cepa b-19 4 - vacunas bacterianas vivas - bovino
lio-b-19 liofilizado y disolvente para suspensión inyectable
laboratorios syva, s.a.u. - brucella abortus, viva atenuada (fase lisa), cepa b-19 - liofilizado y disolvente para suspensiÓn inyectable - brucella abortus, viva atenuada (fase lisa), cepa b-19 50-120 x 10^9 - vacunas bacterianas vivas - bovino
lio-b-19
laboratorios syva, s.a.u. - brucella abortus, viva atenuada (fase lisa), cepa b-19 - liofilizado y disolvente para suspensiÓn inyectable - excipientes: agua para preparaciones inyectables, cloruro de sodio, cloruro potasico, hidrogeno fosfato de disodio anhidro, dihidrogenofosfato de potasio, manitol (e-421), gelatina, trehalosa - vacunas bacterianas vivas - bovino
kyleena 19,5 mg sistema de liberacion intrauterino
bayer hispania s.l. - levonorgestrel - sistema de liberaciÓn intrauterino - 19,5 mg - levonorgestrel 19,5 mg - diu de plástico con progestágeno
spikevax (previously covid-19 vaccine moderna)
moderna biotech spain, s.l. - single-stranded, 5’-capped messenger rna (mrna) produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vacunas - spikevax is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax bivalent original/omicron ba. 1 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 years of age and older who have previously received at least a primary vaccination course against covid-19. spikevax bivalent original/omicron ba. 4-5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax xbb. 5 is indicated for active immunisation to prevent covid 19 caused by sars-cov-2 in individuals 6 months of age and older. the use of this vaccine should be in accordance with official recommendations.
jcovden (previously covid-19 vaccine janssen)
janssen-cilag international nv - adenovirus type 26 encoding the sars-cov-2 spike glycoprotein (ad26.cov2-s) - covid-19 virus infection - vacunas - jcovden is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 18 years of age and older. el uso de esta vacuna debe estar en conformidad con las recomendaciones oficiales.
vaxzevria (previously covid-19 vaccine astrazeneca)
astrazeneca ab - chadox1-sars-cov-2 - covid-19 virus infection - vacunas - vaxzevria is indicated for active immunisation to prevent covid 19 caused by sars cov 2, in individuals 18 years of age and older. el uso de esta vacuna debe estar en conformidad con las recomendaciones oficiales.